Drug Search Results
More Filters [+]

Amitriptylinoxide

Alternative Names: amitriptylinoxide, amitriptyline oxide
Latest Update: 2024-04-29
Latest Update Note: PubMed Publication

Product Description

Amitriptylinoxide is an organic tricyclic compound. Amitriptylinoxide has been used in trials studying Major Depression. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Amitriptylinoxide)

Mechanisms of Action: NET Blocker,SERT Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: HolsboerMaschmeyer NeuroChemie
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Amitriptylinoxide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Depressive Disorder, Major|Psychotic Disorders|Bipolar Disorder

Phase 3: Tic Disorders|Schizophrenia|Dementia|Depressive Disorder|Psychophysiologic Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

GAP

P3

Terminated

Depressive Disorder|Dementia|Psychophysiologic Disorders|Tic Disorders|Schizophrenia

2017-06-28

NCT02237937

P4

Unknown status

Depressive Disorder, Major

2014-12-01

ABCB1 Clinical Study

P4

Active, not recruiting

Bipolar Disorder|Depressive Disorder, Major|Psychotic Disorders

2014-01-30

Recent News Events